Ajinomoto’s amino acid technologies division announced a 10% price increase across all of its markets due to rising costs of manufacturing and transportation.
SGS will soon be able to test up to 30 batches of amino acids for impurities per month after adding new analytical methods to those offered at its laboratory in Taunusstein, Germany.
A group of researchers at Harvard Medical School has developed a strongly cationic nanoparticle that physically absorbs proteins to form a new type of drug-carrier complex in aqueous solution.
Ajinomoto says its flexible approach to tech licensing differs from rivals who are more focused on locking customers into manufacturing services contracts.
Pharma supply chain consortium Rx-360 has advised drugmakers to check their L-Arginine stocks, warning that a recent surge in demand could limit supplies.
Cell penetration and pharmacodynamics boosting “stapled peptide” tech wins Aileron Therapeutics potential billion dollar protein drug development deal with Roche.
Lower overseas demand from key customers hurt fine chemicals maker Synthetech in first quarter fiscal 2011, continuing the decline seen in the previous financial year
Coupling interferon to a synthetic PEG molecule could increase the therapeutic’s dosing schedule from every other day to every one to two weeks, according to researchers who believe the technology has blockbuster potential.
India’s Terrene Pharma has opened what it claims is the only gelatine capsule manufacturing plant in the country to be “designed from inception as per US FDA, EU EDQM and WHO GMP requirements.”
Commonwealth Biotechnologies (CBI) is set to acquire China-based peptide manufacturer GL Biochem, which it believes will create a dominant force in the non-GMP segment of the market.
France-based Flamel Technologies and Merck Serono have shook hands
on a new €2m ($2.9m) deal which would see Flamel's Medusa
technology used to develop an extended-release profile of an
undisclosed therapeutic protein.
The National Institute of Standards and Technology (NIST) has
issued its first ever reference material to improve the performance
and reliability of proteomics research.
A new piece of equipment could enable scientists to study changes
in protein structure, including those necessary to cancer tumour
growth, both faster and more accurately, according to its
developers.
Applied Biosystems has announced the availability of the first
laboratory system that uses mass spectrometry to perform amino acid
analysis, greatly improving the effectiveness and reliability of
the data obtained.
Excelsyn Molecular Development claims to have made a "major
advance" in a protein intensification process that can be used to
slash the manufacturing costs of a range of amino acids.
Biopharmaceutical firm Oragenics has received funding from a US
government agency for a technology which promises cost-effective
production of commercially important bioactive peptides with
unusual structures.
Surface modification firm SurModics has acquired Intralytix's
polyester-amide (PEA) biodegradable polymers, boosting the
company's capacity for specific drug delivery, a capability in high
demand by its customers.
Chemical company BASF has developed a process for the production of
new chiral intermediates for the pharmaceutical industry on a
commercial scale, further raising the product efficiency of drugs
and reducing undesirable effects.
Innovative laboratory technology that produces a sharper picture of
the nano-machine that translates genetic program into proteins
gives a unique insight into how some types of antibiotics work
leading to the design of better ones.
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has won a contract to apply its new method
for manufacturing synthetic peptides...
GWC Technologies claims that its new SpotReady chips enable labs to
carry out label-free array analysis of proteins and other
biomolecules, reports Anthony Fletcher.
Engineers in the US have found a way to modify a plastic so that it
can anchor molecules that promote nerve regeneration, blood vessel
growth or other biological processes.
Sigma, a division of Sigma-Aldrich Corporation has launched a new
offering of Custom AQUA Peptides for use with Protein-AQUA
Quantitative Proteomics, enabling important applications as
differential protein expression, biomarker quantification...
Sales of amino acids used in synthesis applications will reach
nearly $1 billion in 2009 and represent the fastest-growing
category in the $7 billion amino acids market.
Japan's Ajinomoto has developed a revolutionary enzymatic method to
manufacture peptides that could dramatically cut the cost of
producing this growing class of therapeutic agents.
Setting aside the acrimony of a patent dispute, UK separations
company Whatman is to buy German rival Schleicher & Schuell for
€50.2 million, allowing it to narrow the gap between itself and the
main players Pall and Millipore.
US drug delivery company SCOLR Pharma, announced it has filed a
provisional patent application utilizing the company's patented
amino acid technology for the Controlled Delivery Technology (CDT)
extended release form of ondansetron.
Chiral Quest parent VioQuest Pharmaceuticals has been awarded a US
patent covering the use of novel catalysts to increase the
efficiency of chiral amine and amino acid synthesis.
Germany's BASF has entered into a collaboration with Solvias of
Switzerland that will see the two companies combine their expertise
in the development and manufacture of chiral intermediates for the
life science industry.
Kyowa Hakko Kogyo has developed a new process for manufacturing
amino acid dimers - also known as di-peptides - that could increase
their use as components in infusions and enteral nutrition
products.
Solvay subsidiary Peptisyntha is boosting its capacity to make
peptides at its facilities in California, US, in anticipation of
increasing numbers of drugs in this class coming through to market.
Neotame, a recently introduced high intensity sweetener developed
by US company NutraSweet, has been approved by the health
authorities in India for use in pharmaceutical preparations.
Applied Biosystems has unveiled a family of reagents that speeds up
proteomics and biomarker discovery experiments by allowing up to
four peptides to be analysed in single sample, writes Wai Lang
Chu.
Swiss contract manufacturing company Lonza has licensed a
technology that makes it possible to make peptide drugs that are
longer and have a more complex structure than is possible using
conventional techniques, reports Phil Taylor.
A new technique for engineering protein crystals is helping
scientistsfigure out the three-dimensional structures of some
important biological molecules, including a key plague protein
whose structure has eluded researchers until...
German chemistry specialist ChiroBlock has pulled out of the
business of producing and marketing chiral compounds and will focus
exclusively on providing chiral research and synthesis services for
pharmaceutical and biotechnology...
Germany's third-largest chemicals company Degussa has won the Frost
& Sullivan Product of the Year Award for its L-hydantoinase
enzymatic process for single-step production of L-amino acids, used
in the pharmaceutical, food...
Kyowa Hakko reaps the benefit of a strong performance in its
biochemicals business, particularly for amino acids, with a 61.5
per cent rise in operating profit.
BASF has announced that later this summer it will temporarily
suspend production of the amino acid lysine at its facility in
Gunsan, Korea, due to essential maintenance work
